Video Education With Result Dependent dIsclosure

Launched by DANA-FARBER CANCER INSTITUTE · Jan 26, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to educate patients about genetic testing for various types of cancer, including breast, ovarian, pancreatic, prostate, colorectal, renal, melanoma, and sarcoma. The study aims to improve access to a video-based education program called VERDI, which helps patients understand what to expect from genetic testing and how it might affect their health. The goal is to ensure that more diverse groups, particularly Black and Latinx individuals, can benefit from this important information.

To participate in the trial, you need to be at least 18 years old and have a current or past diagnosis of one of the specified cancers. You should also be able to understand English or Spanish in a healthcare setting and be willing to sign a consent form. However, if you have already had genetic testing for cancer or are currently pregnant, you won't be eligible to join. Participants can expect to engage with the video materials and share their thoughts on how well they work for different communities. Your input could help improve education for future patients facing similar health challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
• • Ability to understand spoken or written English or Spanish in a healthcare context
• • Ability to understand and the willingness to sign a written informed consent document
• • Black or Latinx (qualitative assessment study only)
• Exclusion Criteria:
• • Prior cancer genetic testing
• • Prior germline genetic testing
• • Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
• • Currently pregnant
• • Currently incarcerated